Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15663834rdf:typepubmed:Citationlld:pubmed
pubmed-article:15663834lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15663834lifeskim:mentionsumls-concept:C0021390lld:lifeskim
pubmed-article:15663834lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:15663834pubmed:issue5lld:pubmed
pubmed-article:15663834pubmed:dateCreated2005-1-24lld:pubmed
pubmed-article:15663834pubmed:abstractTextPatients with inflammatory bowel disease (IBD) are subject to increased risks for the development of colorectal cancer (CRC), risks that are attributed to the duration and anatomic extent of disease in patients with ulcerative colitis and Crohn's disease. Although IBD contributes only 1%-2% to all cases of CRC, the mortality rate in patients with a diagnosis of CRC in the setting of IBD is higher than for those afflicted with sporadic cases of CRC. Given the length of time from IBD onset to the development of CRC, surveillance continues to be widely practiced. Although still under development, novel techniques for the earlier detection of dysplastic lesions have moved to the forefront in an attempt to optimize surveillance strategies and decrease the risk of CRC development.lld:pubmed
pubmed-article:15663834pubmed:languageenglld:pubmed
pubmed-article:15663834pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15663834pubmed:citationSubsetIMlld:pubmed
pubmed-article:15663834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15663834pubmed:statusMEDLINElld:pubmed
pubmed-article:15663834pubmed:monthJanlld:pubmed
pubmed-article:15663834pubmed:issn1533-0028lld:pubmed
pubmed-article:15663834pubmed:authorpubmed-author:LongoWalter...lld:pubmed
pubmed-article:15663834pubmed:authorpubmed-author:VagefiParsia...lld:pubmed
pubmed-article:15663834pubmed:issnTypePrintlld:pubmed
pubmed-article:15663834pubmed:volume4lld:pubmed
pubmed-article:15663834pubmed:ownerNLMlld:pubmed
pubmed-article:15663834pubmed:authorsCompleteYlld:pubmed
pubmed-article:15663834pubmed:pagination313-9lld:pubmed
pubmed-article:15663834pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:15663834pubmed:meshHeadingpubmed-meshheading:15663834...lld:pubmed
pubmed-article:15663834pubmed:meshHeadingpubmed-meshheading:15663834...lld:pubmed
pubmed-article:15663834pubmed:meshHeadingpubmed-meshheading:15663834...lld:pubmed
pubmed-article:15663834pubmed:meshHeadingpubmed-meshheading:15663834...lld:pubmed
pubmed-article:15663834pubmed:meshHeadingpubmed-meshheading:15663834...lld:pubmed
pubmed-article:15663834pubmed:meshHeadingpubmed-meshheading:15663834...lld:pubmed
pubmed-article:15663834pubmed:meshHeadingpubmed-meshheading:15663834...lld:pubmed
pubmed-article:15663834pubmed:meshHeadingpubmed-meshheading:15663834...lld:pubmed
pubmed-article:15663834pubmed:meshHeadingpubmed-meshheading:15663834...lld:pubmed
pubmed-article:15663834pubmed:meshHeadingpubmed-meshheading:15663834...lld:pubmed
pubmed-article:15663834pubmed:meshHeadingpubmed-meshheading:15663834...lld:pubmed
pubmed-article:15663834pubmed:meshHeadingpubmed-meshheading:15663834...lld:pubmed
pubmed-article:15663834pubmed:year2005lld:pubmed
pubmed-article:15663834pubmed:articleTitleColorectal cancer in patients with inflammatory bowel disease.lld:pubmed
pubmed-article:15663834pubmed:affiliationDepartment of Surgery, Yale University School of Medicine, New Haven, CT 06520, USA.lld:pubmed
pubmed-article:15663834pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15663834pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15663834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15663834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15663834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15663834lld:pubmed